Some visit links earn us a commission.
Quick verdict
Medvi is the better pick for most patients on overall scoring. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Medvi | Eden | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $209/mo (incl. medication) |
| Monthly cost gap | Medvi is $30/mo cheaper than Eden | |
| Lock-in | Month-to-month | 3-mo minimum |
| Time to prescription | 2 days | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Direct | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Medvi | Eden | |
|---|---|---|
| Pricing transparency | 8/10 | 7/10 |
| Cancellation terms | 8/10 | 5/10 |
| Onboarding experience | 7/10 | 8/10 |
| Medication options | 7/10 | 5/10 |
| Member reviews | 9/10 | 9/10 |
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on pricing transparency, cancellation terms, medication options and runs $30/mo cheaper than Eden at the entry tier ($179 vs $209). Over a year that's $360 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
When to choose Eden
Best for lowest sticker price
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
Eden wins on onboarding experience on the dimensional scoring. The caveat: Anyone who values transparent recurring billing or branded medication. Note also: Compounded oral troches are a personalization-claim formulation with thin clinical evidence base.
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $209 for Eden. That's $30 a month or $360a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $90 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Medvi (month-to-month) and Eden (3-mo minimum) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Medvi's easier cancellation is the safer trial.
FAQ
Is Medvi cheaper than Eden?
Can I switch from Medvi to Eden mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
